journal article·2023-08-23

In Vivo Immune Adjuvant Effects of CaCO3 Nanoparticles through Intracellular Ca2+ Concentration Regulation

Huizhu Tan, Kuirong Mao, Xiuxiu Cong, Yanbao Xin, Feiqi Liu, Jialiang Wang, Xin Wang, Jing Han, Yuning Zhang, Yong-Guang Yang, Tianmeng Sun

ACS Applied Materials & Interfaces· Volume 15· Issue 33
Publisher page

Abstract

Calcium (Ca) is a vital component of the human body and plays a crucial role in intracellular signaling and regulation as a second messenger. Recent studies have shown that changes in intracellular Ca 2+ concentration can influence immune cell function. In this study, we developed calcium carbonate nanoparticles (CaNPs) of various sizes using a Nanosystem Platform to modulate intracellular Ca 2+ concentration in vitro and in vivo. Our findings demonstrate that intravenous administration of CaNPs led to changes in the number and ratio of immune cells in the spleen and stimulated the activation of dendritic cells (DCs) and macrophages. Notably, CaNPs exhibited strong adjuvant properties in the absence of antigenic stimuli. These results indicate that CaNPs have the potential to regulate immune cell function by modulating Ca 2+ concentrations, offering a novel approach for disease prevention and treatment in combination with antigens or drugs. Overall, our study emphasizes the importance of modulating intracellular Ca 2+ concentration as a means of regulating immune cell function.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Nanoparticles: synthesis and applications · Erythrocyte Function and Pathophysiology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun, Jilin 130061, China

National-Local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, Jilin 130062, China

International Center of Future Science, Jilin University, Changchun, Jilin 130012, China

State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, Jilin 130012, China

Funding

National Key Research and Development Program of China · First Hospital of Jilin University · Jilin University · National Natural Science Foundation of China · Bethune Medical Department, Jilin University · Department of Human Resource and Social Security of Jilin Province

References (38)

Show source-provided references
1. 10.1016/0958-1669(91)90084-I10.1016/0958-1669(91)90084-I ↗
2. 10.1146/annurev-immunol-032414-11221210.1146/annurev-immunol-032414-112212 ↗
3. 10.1016/bs.ai.2019.11.00710.1016/bs.ai.2019.11.007 ↗
4. 10.1126/scisignal.aaz096110.1126/scisignal.aaz0961 ↗
5. 10.1016/j.cytogfr.2019.04.00310.1016/j.cytogfr.2019.04.003 ↗
6. 10.1038/nri215210.1038/nri2152 ↗
7. 10.1038/s41577-018-0110-710.1038/s41577-018-0110-7 ↗
8. 10.1038/ni116110.1038/ni1161 ↗
9. 10.1038/ni125610.1038/ni1256 ↗
10. 10.1007/s12016-017-8607-610.1007/s12016-017-8607-6 ↗
11. 10.1074/jbc.M60273920010.1074/jbc.M602739200 ↗
12. 10.1016/j.coi.2018.04.00510.1016/j.coi.2018.04.005 ↗
13. 10.1182/blood.V94.4.135910.1182/blood.V94.4.1359 ↗
14. 10.1016/j.molcel.2017.05.02810.1016/j.molcel.2017.05.028 ↗
15. 10.15252/embj.20148905610.15252/embj.201489056 ↗
16. 10.1038/ncb328410.1038/ncb3284 ↗
17. 10.1038/ni.164810.1038/ni.1648 ↗
18. 10.1038/s41423-020-00630-310.1038/s41423-020-00630-3 ↗
19. 10.3390/ijms2121832310.3390/ijms21218323 ↗
20. 10.1038/3258810.1038/32588 ↗
21. 10.1038/nri.2016.11610.1038/nri.2016.116 ↗
22. 10.1038/s41423-021-00726-410.1038/s41423-021-00726-4 ↗
23. 10.1038/cr.2016.15710.1038/cr.2016.157 ↗
24. 10.1016/j.bbrc.2017.12.06410.1016/j.bbrc.2017.12.064 ↗
25. 10.3791/6065910.3791/60659 ↗
26. 10.1016/j.niox.2021.02.00210.1016/j.niox.2021.02.002 ↗
27. 10.1111/andr.1246710.1111/andr.12467 ↗
28. 10.1016/j.cis.2014.04.00110.1016/j.cis.2014.04.001 ↗
29. 10.1016/bs.podrm.2015.11.00310.1016/bs.podrm.2015.11.003 ↗
30. 10.1111/j.1469-7793.2000.00057.x10.1111/j.1469-7793.2000.00057.x ↗
31. 10.4049/jimmunol.180083710.4049/jimmunol.1800837 ↗
32. 10.1038/nrm115010.1038/nrm1150 ↗
33. 10.1038/nrm115510.1038/nrm1155 ↗
34. Smith B. M. · Cancer Res. · 1983 · 43 · 3385
35. 10.1006/bbrc.2000.344710.1006/bbrc.2000.3447 ↗
36. 10.1016/j.msec.2014.08.03110.1016/j.msec.2014.08.031 ↗
37. 10.1016/j.trecan.2021.05.00110.1016/j.trecan.2021.05.001 ↗
38. 10.1039/C9BM00226J10.1039/C9BM00226J ↗